Navigation Links
SemBioSys begins phase I/II trial of insulin produced in plant seeds
Date:12/3/2008

TSX symbol: SBS

CALGARY, Dec. 3 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing protein pharmaceuticals in crop plants, today announced that it has initiated a phase I/II clinical trial of its plant-produced insulin with the first injection of its drug in humans. The trial, taking place in the United Kingdom (UK), will include up to 30 healthy volunteers in a three-arm study (SBS-1000 insulin and two commercial standards) to demonstrate the bioequivalence of safflower-produced insulin to comparator insulin products. Full results are expected to be available during the first half of 2009.

"We have commenced the planned phase I/II clinical trial with plant-made insulin. This is the largest volume biopharmaceutical ever produced in plants," stated Bruce Given, M.D., acting chief medical officer at SemBioSys. "This sophisticated trial is designed to show bioequivalence with respect to insulin concentrations as well as insulin action on blood glucose. Bioequivalence is being measured by comparing SBS-1000 to commercially available insulin currently used to treat diabetes."

"The initiation of the phase I/II clinical trial for plant-produced insulin is a major milestone for SemBioSys. The trial is the first in which plant-produced insulin has been injected into humans and supports the exciting potential for the establishment of plant-produced drugs in the pharmaceutical sector," said Andrew Baum, president and chief executive officer of SemBioSys. "This trial verifies the viability of plant made insulin and defines the regulatory path for plant-made biopharmaceuticals. This trial also represents significant risk reduction for potential large pharmaceutical partners for our insulin and Apo AI Milano programs."

SemBioSys prepared the clinical material in its Current Good Manufacturing Practice (cGMP) compliant manufacturing plant, which underwent a successful cGMP inspection
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
2. SemBioSys announces second quarter 2008 financial and operational results
3. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
4. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
5. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
6. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
7. SemBioSys announces first quarter 2008 financial and operational results
8. SemBioSys receives milestone payments from AVAC Ltd.
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys announces 2007 financial and operational results
11. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...tained follicle stimulant achieves similar efficac...er a one week period in Phase III Study , , AMS...Plough Corp., (NYSE: SGP ) today announced resul...trating that a single injection of corifollitropin...imulants, achieved similar efficacy to recombinant...
(Date:7/1/2009)...Call/ -- NeoStem, Inc. (NYSE Amex: NBS ) announc... of over $4 million from institutional and private...lion private placement from three Asia-based inves...estment obtained by NeoStem in the past two and ha...iates of Suzhou Erye Pharmaceuticals Company, Ltd....
(Date:7/1/2009)...re/ -- SenesTech, Inc., a biotechnology corporatio...ion management, announced the appointment of Georg...ent. , , Siegel has over 35 years of business d...tions. He has served as Chairman of the Board of ...oup, Inc., Director of ILINC Communications, Inc.,...
(Date:6/30/2009)... has modified chlorophyll from an alga so that it ...f bacteria. The team was then able to determine th...irst step to converting sunlight into energy using...shing an article on their research findings in the... week starting 29 June. Leiden researcher Swapna G...
Breaking Biology Technology:Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3SenesTech Announces New Vice President of Business Development 2First step to converting solar energy using 'artificial leaf' 2
...aukesha, Wis. - GE Healthcare has signed a mult...h Excellence in Breast Cancer Imaging within the ...h Imaging Center. , ,With funding from GE Healthca...the center is designed to advance and commercializ...east cancer, and its researchers will conduct brea...
...auwatosa, Wis. - Looking to raise more venture ca...ill be one of 30 firms presenting at the annual I...Overland Park, Kan. , ,ZyStor, which also presente...onal $15 million or more in anticipation of Phase ...008. , ,The company, located in the Technology In...
...adison, Wis. - CIOs must know something that Alan... in a hiring mode in the second quarter of 2007, a...onal information technology hiring. , ,The report,...airman Alan Greenspan forecast a possible recessio...4 percent of CIOs plan to add full-time IT staff i...
...In a recent column for the Wisconsin Technology N...the University of Wisconsin System fueling our s...here is no doubt that the UW System is one of the ...wever, the system must be willing to innovate and ...as created in 1971. The UW System and the Board o...
Other Biology Technology:ZyStor seeks to raise $15M for clinical trials 2ZyStor seeks to raise $15M for clinical trials 3UW System must remove barriers to innovation 2UW System must remove barriers to innovation 3UW System must remove barriers to innovation 4
(Date:7/1/2009)...y a few genes had been associated with the formati...chers of the Max Delbrck Center for Molecular Medi...cine Berlin, Germany, have identified 115 genes th...in its metastases. In the future, their findings m...t an earlier stage ( Gastroenterology 2009, doi:1...
(Date:7/1/2009)...dergraduate students from across the United States...field course in the Russian Arctic. The program, k...aders in arctic research and education, and inform.... , Dr. R. Max Holmes, an associate scientist ...the Polaris Project, says, "The Arctic is central ...
(Date:7/1/2009)...therlands: For the first time, researchers have b...ential success or failure of IVF treatment in bloo...lin, Ireland, told the 25th annual conference of t...yology today (Wednesday 1 July) that her research ...nts but not for others. , Previous work in this ...
(Date:6/30/2009)...The potential of forest biotechnology to help addr... being "strangled at birth" by the rigid oppositio...preclude even the testing of genetically modified ... must be taken to create a regulatory environment ...entific, case-by-case basis, and is focused on the...
Breaking Biology News(10 mins):Colorectal cancer 2International team of students and scientists on month-long field course in Siberian Arctic 2International team of students and scientists on month-long field course in Siberian Arctic 3Will IVF work for a particular patient? The answer may be found in her blood 2Will IVF work for a particular patient? The answer may be found in her blood 3Anti-biotech groups obstruct forest biotechnology 2Anti-biotech groups obstruct forest biotechnology 3New guideline for prescribing opioid pain drugs published 35993 1New guideline for prescribing opioid pain drugs published 35993 2New guideline for prescribing opioid pain drugs published 35993 3Volcano Corporation Schedules Fourth Quarter Conference Call Webcast 35991 1Volcano Corporation Schedules Fourth Quarter Conference Call Webcast 35991 2Cleveland House a Sober living Resort is Celebrating 7 Year Anniversary 35989 1Cleveland House a Sober living Resort is Celebrating 7 Year Anniversary 35989 2Code Pink Boot Camp Thrives Despite Rough Economy 35986 1Code Pink Boot Camp Thrives Despite Rough Economy 35986 2
... Universitat Autònoma de Barcelona (UAB), in coope...-chemical biosensor which detects the presence, in...he most widely used herbicides in agriculture and ...vironment- as well as antibiotics in food. The bio...the expensive laboratory methods which are used to...
... instructions used by the individual cells to prod...ody. Scientists are only beginning to appreciate, ...ised over every step of the production process. ,..., are actively producing proteins in a given cell ...nced by a various mechanisms that act to interfere...
...help explain the brute strength of the tyrannosaur...finding demonstrates how a fused nasal bone helped... , "Fused, arch-like nasal bones are a unique feat...ost doctoral research fellow at the University of ...ng the T. rexes from breaking their own skull whil...
...or example HIV and bird flu able to make the cells...irus? Researchers at the University of Copenhagen ... a collaboration between molecular biologists and ...ge of how the cell functions and of the interplay ...sts have the expertise and the technique to be abl...
Other Biology News:A new portable biosensor detects traces of contaminants in food more quickly and cheaply 2Newly identified mechanism for silencing genes points to possible anti-cancer strategies 2Fused nasal bones helped tyrannosaurids dismember prey 2Danish researches solve virus puzzle 2
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to SGG (Sheep gamma globulin) lysine through amide bonds. This product is homologous to NP-BSA.
MOUSE ANTI HUMAN B-CELLS (FMC7):FITC Immunogen: HRIK cells - Human B-Lymphoblastoid line
...e ideal for use in refrigerators, freezers, or liq...orage racks. Four vibrant colors allow for color c...tom allow liquid nitrogen drainage or promote cool...l) grid which holds 81 tubes. Box dimensions: 13...
RABBIT ANTI PARATHION
Biology Products: